Our data provide the first in vitro observation that BRAF/MEK inhibitors decrease TF in BRAFv600e mutated melanoma cells thus inhibiting the coagulation cascade, adding one more piece of evidence to the complex relationship between coagulation and cancer. This evidence concerns the gene TF and melanoma.